Becton, Dickinson and Company – BD has gone on to introduce the Surgiphor surgical wound irrigation system in Europe.
The system, which has received the CE approval, is at present available across the select nations in the region.
Notably, it is designed as a pre-mixed, sterile irrigation solution in order to assist with the eradication of debris as well as foreign material due to surgical wounds.
It is well to be noted that the solution is intended for application across the procedures, cutting the need for preparation by the hospital staff.
It claims to have in it a trusted antiseptic as a preservative in order to aid in reducing the bacterial load, which is always linked to the risk of certain surgical site infections.
Moreover, the BD Surgiphor also comes with an easy-to-handle design, which enables quick as well as seamless application by surgical teams.
Rian Seger, the BD Surgery worldwide president, said that this European launch goes on to mark quite a prominent landmark when it comes to advancing surgical care.
He adds that the surgical site infections are indeed multifactorial and also continue to present quite major issues to both patient outcomes as well as healthcare systems. Surgiphor goes on to support clinicians in executing the evidence-based practices like surgical wound irrigation in order to help decrease the risk, elevate the recovery, and also upgrade the overall surgical safety.
As per BD, this launch goes on to demonstrate the ongoing focus of the company on progressing surgical care by way of practical solutions, which often prioritize patient safety.
It was in August 2025 that the company had announced an investment of more than $35m to expand the manufacturing capacity of BD PosiFlush prefilled flush syringes at the Columbus facility in Nebraska, US.
This expansion is anticipated to create 50 new jobs and also increase the production so as to meet the growing demand coming from US health systems as well as hospitals.
Recently, BD went on to obtain 510(k) clearance from the US Food and Drug Administration as well as CE marking as per the In Vitro Diagnostic Regulation of the European Union for its bacterial panels when it comes to the usage on the BD COR System.